GE Healthcare Introduces Sonic DL: FDA-Cleared AI for Faster MRI.

Sonic DLi is a deep learning (DL) technology that acquires high-quality magnetic resonance (MR) images up to 12 timesii faster than conventional methods,...

June 06, 2023 | Tuesday | News
Evaxion's AI Identifies Cancer Vaccine Targets Linked to Extended Progression-Free Survival in Melanoma Patients

The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety and tolerability Positive clinical responses were repor...

June 04, 2023 | Sunday | News
New Coalition Launched to Fight Breast and Cervical Cancers Across Asia-Pacific

 Crowell & Moring International is joining forces with Roche, TogetHER for Health, CAPED and Jhpiego to raise awareness about the surge of br...

June 02, 2023 | Friday | News
Bayer Launches Unit to Develop New Precision Health Consumer Products

The Consumer Health Division of Bayer has launched a business unit focused on developing new Precision Health products across its range of everyday health ...

June 01, 2023 | Thursday | News
Sun Pharma and Philogen Partner for Exclusive Distribution, License, and Supply of NIDLEGY™ in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 30, 2023 | Tuesday | News
Novavax's Nuvaxovid™ Receives Positive CHMP Opinion for EU Marketing Authorization in COVID Prevention

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant,  announced that Nuvaxovid&tra...

May 29, 2023 | Monday | News
Lexicon's INPEFA™ (sotagliflozin) FDA Approved for Heart Failure Treatment

INPEFA reduced the risk of total occurrence of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits by 33% compared to ...

May 29, 2023 | Monday | News
KEYTRUDA® + LENVIMA® Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma

After four years of follow-up, KEYTRUDA plus LENVIMA reduced the risk of death by 21% versus sunitinib in the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581...

May 26, 2023 | Friday | News
FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria

According to the World Health Organization, Acinetobacter species top the list of critical bacterial pathogens that pose the greatest threat to human ...

May 24, 2023 | Wednesday | News
Indivior Receives FDA Approval for OPVEE® Nasal Spray, Opioid Overdose Rescue Medicine

In the 12-month period ending in December 2022, over 79,000 people in the U.S. were reported to have died of an opioid overdose, of whi...

May 23, 2023 | Tuesday | News
Rakuten Medical Initiates Global Phase 3 Trial of Alluminox™ Treatment for Head and Neck Cancer in India

The Company has been granted permission from the Indian Central Drugs Standard Control Organization (CDSCO) to conduct its global, pivotal Phase 3 clinical...

May 23, 2023 | Tuesday | News
World’s Largest HIV/AIDS Organization Warns of Monkeypox Resurgence

AIDS Healthcare Foundation (AHF), the world’s largest HIV and AIDS healthcare organization, is seeing a reemergence of monkeypox (now known as mpox) ...

May 19, 2023 | Friday | News
Max Foundation, BeiGene, and BeiGene Foundation Collaborate for Health Equity, Providing Access to BRUKINSA® in Low- and Middle-Income Countries

“We are thrilled to partner with BeiGene to help people living with CLL in low- and middle-income countries have access to BRUKINSA,” said Pat ...

May 19, 2023 | Friday | News
Health Canada accepts New Drug Submission for lecanemab as treatment for early Alzheimer's disease

The NDA is based on the results of the Phase 3 Clarity AD study and the Phase 2b clinical study, which demonstrated that lecanemab treatment showed a reduc...

May 16, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close